Mesh Bio - About the company
Mesh Bio is a series A company based in Singapore (Singapore), founded in 2018 by Melvin Heng, Arsen Batagov and Andrew Wu. It operates as a Provider of chronic disease management software. Mesh Bio has raised $6.5M in funding from investors like East Ventures, Enterprise Singapore and Elev8. The company has 274 active competitors, including 70 funded and 19 that have exited. Its top competitors include companies like Verily, Wellframe and Closedloop Medicine.
Company Details
Mesh Bio provides software for chronic disease management through predictive analytics. The software translates clinical data and numbers into actionable insights that help patients better manage their health, lifestyle, and disease risks. The software provides clinical decision support for healthcare professionals
- Website
- www.meshbio.com/
- Email ID
- *****@meshbio.com
Key Metrics
Founded Year
2018
Location
Singapore, Singapore
Stage
Series A
Total Funding
$6.5M in 2 rounds
Latest Funding Round
Investors
Ranked
16th among 274 active competitors
Annual Revenue
362K SGD as on Dec 31, 2022
Employee Count
27 as on May 31, 2026
Legal entities associated with Mesh Bio
Mesh Bio is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
MESH BIO PTE. LTD. CIN: 201820887D , Singapore, Active | Jun 19, 2018 | $263K (As on Dec 31, 2022) | - |
Sign up to download Mesh Bio's company profile
Mesh Bio's funding and investors
Mesh Bio has raised a total funding of $6.5M over 2 rounds. Its first funding round was on Mar 10, 2021. Its latest funding round was a Series A round on Oct 12, 2023 for $*****. 3 investors participated in its latest round. Mesh Bio has 10 institutional investors and 8 angel investors.
Here is the list of recent funding rounds of Mesh Bio:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 12, 2023 | 7827064 | Series A | 3060757 | 9071603 | 6309403 | 1323090 |
Mar 10, 2021 | 6613986 | Seed | 2123308 | 1715187 |
View details of Mesh Bio's funding rounds and investors
Mesh Bio's founders and board of directors
Founder? Claim ProfileThe founders of Mesh Bio are Melvin Heng, Arsen Batagov and Andrew Wu. Andrew Wu is the CEO of Mesh Bio.
Here are the details of Mesh Bio's key team members:
- Melvin Heng: Co-Founder & Advisor of Mesh Bio. They serve on the board of 1 company.Contact Info: 1 email address
- Arsen Batagov: Co-Founder & CTO of Mesh Bio. They serve on the board of 1 company.
- Andrew Wu: Co-Founder & CEO of Mesh Bio. They serve on the board of 1 company.Contact Info: 1 email address
Mesh Bio's Board of Directors
Mesh Bio's board has 6 active members. Arsen Batagov and Andrew Wu are part of team and Willson Cuaca, Aditya Mathur, Anastasia Ling Yew Lin and Reuben Lai Yuen Tung are independent board members.Here is the list of Mesh Bio's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 7y 3m | |
Team | - | Current | 7y 11m | |
ncoijwb | Team | - | Past | 9y 7m |
Independent board member | - | Current | 1y 11m | |
yhatcqz | Independent board member | - | Current | 4y 4m |
dfnjvzt | Independent board member | - | Current | 5y 3m |
ediissm | Independent board member | - | Past | 4y 4m |
syjj{tr | Independent board member | - | Past | 5y 5m |
View details of Mesh Bio's Founder profiles and Board Members
Mesh Bio's employee count trend
Mesh Bio has 27 employees as of May 26. Here is Mesh Bio's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Mesh Bio's Competitors and alternates
Top competitors of Mesh Bio include Verily, Wellframe and Closedloop Medicine. Here is the list of Top 10 competitors of Mesh Bio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Verily 2015, Dallas (United States), Series D | Developer of precision health platforms and solutions using artificial intelligence | $2.8B | 79/100 | |
2nd | Wellframe 2011, Boston (United States), Acquired | Mobile and AI-based platform offering support to providers for better patient engagement | $45.1M | 67/100 | |
3rd | Closedloop Medicine 2017, Cambridge (United Kingdom), Series A | Developer of personalized medicine platforms combining drug therapy and digital care | $30M | 66/100 | |
4th | Rimidi Diabetes 2012, Coral Gables (United States), Acquired | Cloud-based platform for diabetes management | $12.8M | 64/100 | |
5th | Memora Health 2015, Boston (United States), Acquired | Mobile platform for chronic disease management | $80.6M | 63/100 | |
6th | VitalTech 2002, Plano (United States), Acquired | Provider of a cloud-based platform for monitoring patient and employee health | $26.3M | 62/100 | |
7th | Brook 2015, Series A | Provider of remote patient care blending clinical teams with artificial intelligence | $32M | 61/100 | |
8th | Glytec 2005, United States, Series C | Cloud based platform for diabetes and insulin management | $56.3M | 57/100 | |
9th | TimeDoc 2015, Chicago (United States), Series B | Provider of the chronic care management solution for healthcare professionals | $56.7M | 56/100 | |
10th | ThoroughCare 2013, Spartanburg (United States), Series A | Care coordination software and clinical guidance to optimize patient care management | $11M | 55/100 | |
16th | Provider of chronic disease management software | $6.5M | 50/100 |
Looking for more details on Mesh Bio's competitors? Click here to see the top ones
Mesh Bio's Investments and acquisitions
Mesh Bio has made no investments or acquisitions yet.
Reports related to Mesh Bio
Here is the latest report on Mesh Bio's sector:
News related to Mesh Bio
•
To encourage at least $220 M in investments in deep tech startups, SEEDS Capital appointed 20 new partnersIncubees•Feb 10, 2025•SEEDS Capital, Valuence Ventures, Paspalis, Global Brain and 11 others
•
Double Take: This Singapore Healthtech Startup Develops ‘Digital Twins’ To Manage Chronic DiseasesForbes Middle East•Feb 05, 2024•Mesh Bio, East Ventures, Elev8, SEEDS Capital
•
East Ventures leads to the Mesh Bio series funding US $ 3.5 millionSWA Online•Jan 30, 2024•East Ventures, Mesh Bio, elev8, SEEDS Capital
•
Mesh Bio to expand healthcare platform’s SEA reach with new capitalTech in Asia•Jan 29, 2024•Mesh Bio, East Ventures, elev8, Elev8 and 2 others
•
Singapore’s Mesh Bio attains regulatory approval for HealthVector DiabetesTechNode•Oct 27, 2023•Mesh Bio
•
East Ventures Raises Special Funds Rp. 472 Billion for Indonesian Health Startupsradaraktual.com•Oct 19, 2023•East Ventures, Mesh Bio, AMILI, Aevice Health and 1 other
•
Singaporean health deep tech startup Mesh Bio secures investment from East VenturesTechNode•Oct 12, 2023•Mesh Bio, East Ventures, Tokopedia, Traveloka and 11 others
•
Mesh Bio raises new capital to better fight chronic diseasesTech in Asia•Oct 12, 2023•Mesh Bio, East Ventures
•
Mesh Bio to extend advance digital preventive healthcare in IndonesiaBioSpectrum Asia•Mar 18, 2023•Pramita, Mesh Bio
•
Singapore-based startup Mesh Bio addresses chronic metabolic diseases within AsiaBioSpectrum Asia•Jul 01, 2022•Multiomic Health, Mesh Bio
Are you a Founder ?
FAQs about Mesh Bio
Explore our recently published companies
- Firm - Zielona Gora based, 1998 founded, Unfunded company
- Pbgventures - Unfunded company
- LAN Management Development Service - Sri Lanka based, 1991 founded, Unfunded company
- Stewartelevatorconsulting - United States based, Unfunded company
- Matgci - 1982 founded, Unfunded company
- Marinetheatre - United Kingdom based, 1894 founded, Public company
_1573639702722.png?format=webp&height=120&width=120)